Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RAD52 motif 1 pseudogene is a genomic sequence that shares sequence similarity to the functional RAD52 motif-containing gene family but has lost the ability to encode a functional protein product due to disruptive mutations or loss of necessary regulatory elements. Pseudogenes like this can arise from gene duplication or retrotransposition but are rendered inactive by frameshifts, nonsense mutations, or lack of expression. They are not considered therapeutic targets, and no drugs, mechanisms of action, or disease roles are applicable unless future research identifies a non-canonical regulatory role[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAD52 motif 1 pseudogene.